Methods for increasing sepiapterin plasma exposure
US11617752B2 · kind B2 · utility
3Cited by
22References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 30, 2019 |
| Grant date | Apr 4, 2023 |
| Priority date | — |
| Expiry date | May 30, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention features compositions including sepiapterin, or a pharmaceutically acceptable salt thereof, and methods for the treatment of BH4-related disorders. In some embodiments, these compositions and methods result in an increase in plasma, CSF, and/or brain exposure of sepiapterin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.